LENSAR Inc (LNSR) vs Pulmonx Corporation (LUNG)
A side-by-side comparison of LENSAR Inc and Pulmonx Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LNSR
LENSAR Inc
$6.73HealthcareDelayed quote: Oct 6, 2026, 11:04 AM EDT
LUNG
Pulmonx Corporation
$1.90HealthcareDelayed quote: Oct 6, 2026, 11:05 AM EDT
Total return — LNSR vs LUNG
growth of $100 · dividends reinvested · last 6yLNSR -25.9% (-4.9%/yr)LUNG -95.2% (-39.8%/yr)LNSR compounded faster over this window
Log scale — wide-divergence pair
LNSR LUNG
LNSR vs LUNG: by the numbers
- •LNSR is the larger company ($83M vs $80M market cap).
- •LNSR is profitable (57.57% net margin) while LUNG runs a net loss (-55.03%).
- •LUNG grew revenue faster over the past five years (15.86% vs 14.67% CAGR).
Metrics side by side
Valuation
| Metric | LNSR | LUNG |
|---|---|---|
| P/S ratio | 1.37 | 0.92 |
| P/B ratio | 5.55 | 2.04 |
Profitability
| Metric | LNSR | LUNG |
|---|---|---|
| Gross margin | 47.96% | 77.06% |
| Operating margin | -42.06% | -52.96% |
| Net margin | 57.57% | -55.03% |
| ROE | 232.78% | -122.76% |
| ROIC | -16.28% | -48.39% |
Growth (annualized)
| Metric | LNSR | LUNG |
|---|---|---|
| Revenue CAGR (5Y) | 14.67% | 15.86% |
| Total return CAGR (5Y) | -3.18% | -45.30% |
Frequently asked
- Which has grown faster, LNSR or LUNG?
- Over the past five years, LUNG grew revenue faster — LNSR at a 14.67% CAGR versus LUNG at 15.86%.
- Is LNSR or LUNG more profitable?
- LNSR runs the higher net margin — LNSR at 57.57% versus LUNG at -55.03%.
- How have LNSR and LUNG total returns compared?
- Over the past 5 years, LNSR delivered -3.18% and LUNG delivered -45.30% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
LENSAR ROEPulmonx ROELENSAR operating marginPulmonx operating marginLENSAR revenue growthPulmonx revenue growthLENSAR free cash flowPulmonx free cash flow
LENSAR & Pulmonx appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.